Start-ups & Opportunities
Artiva shutting down cell therapy, cuts 94% of staff after two trial deaths
Artiva Biotherapeutics is dropping its AlloNK autoimmune cell therapy and cutting 94% of staff after two trial deaths, it said on October 27, 2026.
28 Oct 2026, 19:11 IST